Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 21 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-0.42 Insider Own26.29% Shs Outstand69.67M Perf Week-8.09%
Market Cap150.77M Forward P/E- EPS next Y-0.54 Insider Trans0.00% Shs Float51.45M Perf Month-20.30%
Income-28.95M PEG- EPS next Q-0.13 Inst Own2.56% Short Float0.05% Perf Quarter-27.27%
Sales0.00M P/S- EPS this Y-17.23% Inst Trans2.96% Short Ratio0.66 Perf Half Y-25.65%
Book/sh1.13 P/B1.91 EPS next Y-9.67% ROA-26.50% Short Interest0.02M Perf Year-47.12%
Cash/sh1.16 P/C1.87 EPS next 5Y- ROE-32.48% 52W Range2.15 - 4.37 Perf YTD-28.24%
Dividend Est.- P/FCF- EPS past 5Y- ROI-31.83% 52W High-50.57% Beta0.73
Dividend TTM- Quick Ratio11.60 Sales past 5Y0.00% Gross Margin- 52W Low0.46% ATR (14)0.12
Dividend Ex-Date- Current Ratio11.60 EPS Y/Y TTM-77.30% Oper. Margin0.00% RSI (14)28.61 Volatility3.40% 5.04%
Employees121 Debt/Eq0.16 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price9.25
Option/ShortNo / Yes LT Debt/Eq0.15 EPS Q/Q3.21% Payout- Rel Volume0.88 Prev Close2.26
Sales Surprise- EPS Surprise13.66% Sales Q/Q- EarningsMay 20 AMC Avg Volume36.63K Price2.16
SMA20-12.08% SMA50-14.78% SMA200-28.07% Trades Volume32,115 Change-4.42%
Date Action Analyst Rating Change Price Target Change
Dec-15-23Initiated Citigroup Buy $8
Apr-24-23Initiated H.C. Wainwright Buy $9
Apr-14-22Initiated Cantor Fitzgerald Overweight $20
Apr-08-22Initiated Piper Sandler Overweight $19
Apr-04-22Initiated Citigroup Buy $21
May-21-24 08:45AM
May-20-24 09:53PM
May-13-24 08:30AM
May-06-24 08:30AM
08:30AM Loading…
May-01-24 08:30AM
Mar-25-24 08:50AM
Mar-07-24 10:53PM
Feb-26-24 08:30AM
Jan-22-24 09:40AM
Dec-20-23 09:15AM
Dec-05-23 10:25AM
Nov-29-23 08:30AM
Nov-28-23 08:30AM
08:30AM Loading…
Nov-20-23 08:30AM
Nov-16-23 04:30PM
Nov-01-23 08:30AM
Oct-31-23 07:00AM
Oct-30-23 08:30AM
Oct-24-23 09:00AM
Oct-04-23 07:00AM
Oct-03-23 07:00AM
Sep-14-23 08:30AM
Aug-28-23 04:02PM
Aug-24-23 08:00AM
Aug-17-23 05:00PM
Aug-08-23 07:00AM
Aug-06-23 08:28AM
09:00AM Loading…
Aug-02-23 09:00AM
Jun-13-23 08:00AM
May-24-23 04:01PM
May-23-23 04:01PM
May-17-23 04:30PM
May-11-23 04:00PM
May-03-23 04:00PM
Apr-03-23 09:10AM
Mar-29-23 04:00PM
Mar-12-23 08:30AM
Mar-09-23 04:10PM
Mar-08-23 05:00PM
Mar-03-23 08:30AM
Mar-01-23 08:30AM
Feb-21-23 04:00PM
Dec-13-22 08:00AM
Nov-22-22 04:02PM
Nov-09-22 08:00AM
Oct-21-22 04:01PM
Sep-08-22 04:05PM
Sep-01-22 04:15PM
Aug-30-22 04:05PM
Aug-25-22 04:05PM
Aug-22-22 09:00AM
Jul-05-22 04:01PM
Jun-22-22 04:01PM
Jun-16-22 04:01PM
Jun-08-22 09:10AM
Jun-07-22 04:03PM
May-26-22 04:05PM
May-23-22 09:00AM
Apr-12-22 10:39AM
Mar-28-22 08:00AM
Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.